<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092017000200060</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síndrome de encefalopatía posterior reversible en eclampsia en el Hospital Regional de Alta Especialidad de la Mujer de Tabasco, México]]></article-title>
<article-title xml:lang="en"><![CDATA[Reversible posterior encephalopathy syndrome in eclampsia in the Hospital Regional de Alta Especialidad de la Mujer de Tabasco, México.]]></article-title>
<article-title xml:lang="pt"><![CDATA[Síndrome de encefalopatia reversível na eclâmpsia no Hospital Regional de Alta Especialidade de Mulheres em Tabasco, México]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morales Muñoz]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acuña Euán]]></surname>
<given-names><![CDATA[Adriana Mercedes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Padilla Chávez]]></surname>
<given-names><![CDATA[Rosa María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Hernández]]></surname>
<given-names><![CDATA[Clara Magdalena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Trejo]]></surname>
<given-names><![CDATA[Matilde Cecilia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Regional de Alta Especialidad de la Mujer de Tabasco  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Unidad de Especialidad Médica de Imagenología de Villahermosa  ]]></institution>
<addr-line><![CDATA[ Tabasco]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2017</year>
</pub-date>
<volume>31</volume>
<numero>2</numero>
<fpage>60</fpage>
<lpage>64</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092017000200060&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092017000200060&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092017000200060&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: El síndrome de encefalopatía posterior reversible (PRES) se caracteriza por manifestaciones neurológicas asociadas a edema cerebral posterior hemisférico transitorio y se relaciona con el síndrome de preeclampsia-eclampsia.  Objetivo:  Identificar la incidencia del síndrome PRES en pacientes con eclampsia ingresadas a la Unidad de Cuidados Intensivos de Adultos (UCIA) del Hospital Regional de Alta Especialidad de la Mujer (HRAEM) y comparar los factores de riesgo asociados.  Material y métodos:  Observacional, retrospectivo, analítico, transversal y de cohorte de pacientes ingresadas con diagnóstico de eclampsia a la UCIA del HRAEM en el periodo de enero de 2010 a diciembre de 2015.  Resultados:  La incidencia obtenida fue de 57%. Las variables maternas significativas: edad (p = 0.034), número de crisis convulsivas (p = 0.001), edad media de 20.4 ± 6.5 años. La cefalea se observó en 91.5%. En 85% se detectó eclampsia anteparto. La vía de interrupción fue 77% por vía abdominal. La topografía de la lesión se manifestó como multifocal y bilateral en el lóbulo parietal y occipital.  Conclusiones:  La incidencia fue de 57%. Se estableció un perfil de alto riesgo de PRES en pacientes con eclampsia anteparto, primigestas, menores de 21 años, con presión arterial media mayor de 120 mmHg y con más de dos crisis convulsivas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: The syndrome of reversible posterior encephalopathy (PRES) presents neurological manifestations associated to transient hemispheric posterior cerebral edema, is related to the syndrome of preeclampsia-eclampsia.  Objective:  To identify the incidence of PRES in patients with Eclampsia admitted to the ICU of the High Specialty Women&#8217;s Hospital and to compare the associated risk factors.  Material and methods:  Observational, retrospective, analytical, cross-sectional and cohort study of patients admitted to the ICU with the diagnosis of Eclampsia of the Regional High Specialty Hospital from January 2010 to December 2015.  Results:  The incidence was 57%. Significant maternal variables: age (p = 0.034) and number of seizures (p = 0.001), with a mean age of 20.4 ± 6.5 years. The headache was present in 91.5%. Eighty-five percent had antepartum eclampsia. The route of interruption was 77% by the abdominal route. The topography of the lesion was multifocal and bilateral, in the parietal and occipital lobe.  Conclusions:  The incidence was 57%. A high-risk profile for PRES in patients with antepartum eclampsia, primigravidae, younger than 21 years, with a mean arterial pressure greater than 120 mmHg, and who have presented more than two seizures were established.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: A síndrome de encefalopatia posterior reversível (PRES), na eclâmpsia, apresenta manifestações neurológicas associadas ao edema cerebral transitório.  Objetivo:  Identificar a incidência da PRES em pacientes com eclâmpsia internadas na UTI e comparar os fatores de risco associados.  Material e Métodos:  Foram 311 pacientes internadas na UTI em um período de 5 anos com diagnóstico de eclâmpsia, divididos en 2 grupo: PRES (n = 176) e sem PRES (n = 135). Estudo observacional, retrospectivo, analítico, transversal e coorte.  Resultados:  A incidência encontrada foi de 57%. No grupo da PRES a idade foi de 20 ± 6,5 vs 21 ± 5.7 anos, no grupo sem PRES (p = 0.034). Número de crises convulsivas 2 ± 2 vs 1.8 ± 1.8 eventos (p = 0.001), proteinúria 1355 ± 175 vs 930 ± 92 miligramos em 24 horas (p = 0.000) e PAM 120 ± 20 vs 115 ± 15 mmHg (p = 0.011), respectivamente. Mortalidade perinatal foi de 8.6% vs 3.5% (p = 0.05). 85% apresentou eclâmpsia antepartum. A interrupção da gestação foi de 77% pela via abdominal. A topografia da lesão cerebral foi multifocal e bilateral. O odds ratio para associarse a PRES foram: proteinúria, eclâmpsia antepartum, cesárea, PAM &gt; 110mmHg com OR 3, 2.9, 2.5 e 2.3 respectivamente (p &#8804; 0.05).  Conclusões:  A incidência da PRES foi de 57%. Se estabeleceu um perfil de alto risco para PRES em pacientes com eclâmpsia antepartum, menores de 21 anos, PAM 120 mmHg e a presença de duas crisis convulsivas. A mortalidade perinatal se associou a PRES.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Encefalopatía posterior reversible]]></kwd>
<kwd lng="es"><![CDATA[eclampsia]]></kwd>
<kwd lng="es"><![CDATA[embarazo]]></kwd>
<kwd lng="en"><![CDATA[Reversible posterior encephalopathy]]></kwd>
<kwd lng="en"><![CDATA[eclampsia]]></kwd>
<kwd lng="en"><![CDATA[pregnancy]]></kwd>
<kwd lng="pt"><![CDATA[Encefalopatia posterior reversível]]></kwd>
<kwd lng="pt"><![CDATA[eclâmpsia]]></kwd>
<kwd lng="pt"><![CDATA[gestação]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrillo]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Echevarría]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[De los Ríos]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de encefalopatía reversible posterior]]></article-title>
<source><![CDATA[Med Int Mex]]></source>
<year>2013</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>299-306</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>American College of Obstetricians and Gynecologist</collab>
<source><![CDATA[Diagnosis and Management of Preeclampsia and Eclampsia. Centers for Disease Control and Prevention]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Washington DC ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Base de datos básicos de salud</collab>
<source><![CDATA[Iniciativa Regional de Indicadores Básicos de Salud, Organización Panamericana de la Salud (OPS)]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<source><![CDATA[Sistema Automatizado de Egresos Hospitalarios (SAEH) 2010-2015]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartynski]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features]]></article-title>
<source><![CDATA[AJNR Am J Neuroradiol]]></source>
<year>2008</year>
<volume>29</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1036-42</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hobson]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
<name>
<surname><![CDATA[Craven]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Blank]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Peritoneal Dialysis International]]></article-title>
<source><![CDATA[Journal of the International Society for Peritoneal Dialysis]]></source>
<year>2012</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>590-4</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hinchey]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chaves]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Appignani]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Breen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pao]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A reversible posterior leukoencephalopathy syndrome]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1996</year>
<volume>334</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>494-500</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brewer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Owens]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
<name>
<surname><![CDATA[Wallace]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Reeves]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Morris]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2013</year>
<volume>208</volume>
<page-range>468</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Acquah]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Lindell]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Craici]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Wingo]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Rose]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control]]></article-title>
<source><![CDATA[Mayo Clin Proc]]></source>
<year>2011</year>
<volume>86</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>851-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bembalgi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kamate]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Shruthi]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A study of eclampsia cases associated with posterior reversible encephalopathy syndrome]]></article-title>
<source><![CDATA[J Clin Diagn Res]]></source>
<year>2015</year>
<volume>9</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>QC05-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Wijdicks]]></surname>
<given-names><![CDATA[EFM]]></given-names>
</name>
<name>
<surname><![CDATA[Manno]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rabinstein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical spectrum of reversible posterior leukoencaphalopathy syndrome]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2008</year>
<volume>65</volume>
<page-range>205-10</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hossain]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Panhwar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Noureen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical spectrum of posterior reversible encephalopathy syndrome (PRES) in patients with eclampsia]]></article-title>
<source><![CDATA[Pak J Med Sci]]></source>
<year>2015</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1121-3</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Godawari]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Purohit]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cranial MR imaging in eclampsia and severe preeclampsia: a prospective study]]></article-title>
<source><![CDATA[Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology]]></source>
<year>2012</year>
<volume>3</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>3250-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Brewer]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Blake]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
<name>
<surname><![CDATA[Owens]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
<name>
<surname><![CDATA[LaMarca]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PP137. Posterior reversible encephalopathy syndrome (PRES) is a constant component of eclampsia]]></article-title>
<source><![CDATA[Pregnancy Hypertens]]></source>
<year>2012</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>314</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
